Financials data is unavailable for this security.
View more
Year on year Immuneering Corp 's revenues fell -100.00% from 316.95k to 0.00. has fallen 5.86% from a loss of 50.51m to a larger loss of 53.47m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -55.52% |
---|---|
Return on equity | -61.81% |
Return on investment | -59.10% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Immuneering Corp fell by 13.23m. Cash Flow from Financing totalled 28.44m or -- of revenues. In addition the company used 48.97m for operations while cash from investing totalled 7.30m.
Cash flow per share | -1.89 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.24 |
---|---|
Tangible book value per share | 2.00 |
More ▼
Balance sheet in USDView more
Current ratio | 9.39 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼